1) Hemodilution Autologous blood transfusion
血液稀释自身输血
2) hemodilution auto-transfusion
稀释性自身输血
1.
Objective To explore the feasibility and security of the hemodilution auto-transfusion for selective operation.
目的探讨稀释性自身输血在择期手术中的可行性和安全性。
4) hemodilution
[,hi:məudai'ljuʃən]
血液稀释
1.
Influence of acute hypervolemic hemodilution on peri-operative renal function in patients undergoing gastrointestinal tumor operation;
急性高容量血液稀释对胃肠道肿瘤患者围术期肾功能的影响
2.
Comparation of Effect of Acute Hypervolemic Hemodilution with VOLUVEN and HES;
万汶与贺斯应用于急性高容量血液稀释的效果比较
3.
Clinical Research on Reducing Homologous Blood Transfusion in Ectopic Pregnancy by Acute Hemodilution before Operation;
术前急性血液稀释减少异位妊娠手术异体输血的临床研究
5) haemodilution
血液稀释
1.
Effect of sequent use of low central venous pressure anesthesia and acute hypervolemic haemodilution on perioperative blood conservation in hepatic resections;
低中心静脉压麻醉并急性高容血液稀释序贯用于肝叶切除围术期血液保护(英文)
2.
Effects of acute hypervolaemic haemodilution with different plasma substitutes on patients haemorheologic indexes;
不同血浆代用品急性高容量血液稀释对患者血液流变学的影响
3.
Effect of acute normovolemic haemodilution on blood conservation in neurosurgical patients;
急性等容血液稀释用于颅脑外科围术期血液保护(英文)
6) hypervolemic hemodilution
血液稀释
1.
A study of slight acute hypervolemic hemodilution combined with controlled hypotension in meningioma surgery of 30 cases;
急性高容量血液稀释联合控制性降压用于30例脑膜瘤手术的临床观察
2.
Objective To compare the alterations of coagulation function and electrolytes during hypervolemic hemodilution induced by polyglucose and sodium chloride infusion(groupⅠ) and 6% hydroxyethyl starch(groupⅡ).
目的对比观察缩合葡萄糖氯化钠溶液和6%羟乙基淀粉溶液用于扩容性血液稀释期间凝血功能及电解质的变化。
3.
To compare the changes of coagulation during hypervolemic hemodilution induced by gelofusine (G) or gelofusine containing calcium gluconate (calglucon), 30 neurosurgical patients without heart diseases were randomly allocated into three groups.
为对比观察不同剂量的葡萄糖酸钙对佳乐施扩容性血液稀释性凝血功能抑制的预防作用 ,将 30例颅脑手术病人分为 3组 ,Ⅰ组单独用佳乐施 ,Ⅱ组、Ⅲ组佳乐施中葡萄酸钙的加入量分别为 1g/L和 2 g/L。
补充资料：血液稀释
血液稀释
hemodilution
是一种以不含红细胞的液体使血液血细胞比容降低的措施。稀释程度应保持血红蛋白不低于80g/L，血细胞比容大于0.20。在此水平以上循环血量加快，心排出量及微循环血量增加，提高了组织的灌注及保证氧的摄入。常用的有晶体液如乳酸钠林格液，单独应用时输入量必须是所缺失血容量的2～3倍，方能维持血容量的正常。由于胶体渗透压下降，易有血管外液的滞留和水肿。胶体液如人体血浆的蛋白液，代血浆(中分子右旋糖酐、羟乙基淀粉、明胶等)，人体血浆均可作为适宜的稀释液。但实际应用中以晶体为主，适当加输胶体液。有条件时稀释过程应注意中心静脉压及心率的监测，对心力衰竭、冠心病、慢性梗阻性肺疾患均应视为血液稀释的禁忌证。目前血液稀释法已被公认为节约用血、防止血液污染和输血后并发症的最佳方法。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条